Abstract
Proteases and peptidases in Trypanosoma cruzi are considered potential targets for antichagasic chemotherapy. We monitored changes in low-mass metabolites in T. cruzi epimastigotes treated with bestatin, a dipeptide metalloaminopeptidase inhibitor. After treatment, multiple dipeptides were shown to be increased, confirming in situ inhibition of the leucine aminopeptidase of T. cruzi (LAPTc) and probably other peptidases.
Original language | English |
---|---|
Pages (from-to) | 2921-2925 |
Number of pages | 5 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 59 |
Issue number | 5 |
DOIs | |
Publication status | Published - 1 May 2015 |